Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency Therapeutics To Contact Him Directly To Discuss Their Options
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Frequency Therapeutics, Inc. (“Frequency” or the “Company”) (NASDAQ: FREQ) and reminds investors of the August 2, 2021 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
If you suffered losses exceeding $50,000 investing in Frequency stock or options between November 16, 2020 and March 22, 2021 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also fill out the form below for additional information. There is no cost or obligation to you.
Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Delaware, Pennsylvania, California, and Georgia.
As detailed below, the lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements regarding the Company’s Phase 2a study of FX-322, a potential therapy designed to improve hearing function.
Specifically, before the market opened on Tuesday, March 23, 2021, Frequency disclosed in a press release deeply disappointing interim Phase 2a results, revealing that subjects with mild to moderate SNHL did not demonstrate improvements in hearing measures versus placebo.
These results dramatically undercut the narrative the Company had spun since Frequency’s IPO and investors reacted accordingly. That day, Frequency’s shares fell from $36.29 to $7.99, a 78% drop, representing a decline in the Company’s market capitalization of approximately $955 million.
Frequency Therapeutics, Inc.
* The submission of this form does not create an attorney-client relationship.
Filed on 07/12/2021
Lead Plaintiff Deadline 08/02/2021
685 Third Avenue 26th Floor
10017 New York, New York
Phone (212) 983-9330
Fax (212) 983-9331
James M. Wilson, Jr. firstname.lastname@example.org Phone (212) 983-9330 Fax (212) 983-9331
Robert W. Killorin email@example.com Phone (404) 847-0617 Fax (404) 506-9534